ADHD medications use and risk of mortality and unintentional injuries: a population-based cohort study
ADHD medications use and risk of mortality and unintentional injuries: a population-based cohort study
We assessed the association between the use of medications for attention-deficit/hyperactivity disorder (ADHD) and the risk of all-cause mortality and unintentional injuries leading to emergency department (ED) or hospital admission in individuals aged ≤24 years with ADHD. We conducted a population-based retrospective cohort study between 2000 and 2021 using Quebec health administrative data. Individuals were followed from the first ADHD diagnosis or ADHD medication claim until turning 25, death, or study end. Exposure was defined as mutually exclusive episodes of ADHD medication use and/or coverage under the public provincial drug plan (PDP): 1) covered and not treated with ADHD medication; 2) covered and treated with ADHD medication; and 3) not covered under the PDP. The risk of all-cause mortality and unintentional injuries associated with exposure episodes was estimated using multivariable survival analyses. The cohort included n=217 192 individuals aged 1 to 24 years with a male to female ratio of close to 2:1. Compared to non-medication use, episodes of ADHD medication use, overall, were associated with reduced all-cause mortality (adjusted hazard ratio, aHR 0.61, 95% CI 0.48 to 0.76) and unintentional injury leading to ED (0.75, 0.74 to 0.77) or hospitalisation (0.71, 0.68 to 0.75). Episodes of stimulants were associated with a lower risk of all-cause mortality and reduced risk of unintentional injuries, while episodes with non-stimulants and with both stimulants and non-stimulants concomitantly were associated with reduced risk of unintentional injuries, but not of all-cause mortality. Although residual confounding cannot be excluded, stimulants may have a protective effect in terms of risk of all-cause mortality and both stimulants and non-stimulants for ADHD may reduce the risk of unintentional injuries. Clinical implications of findings are that the risk of all-cause mortality was lower during episodes of stimulant use for ADHD but not with non-psychostimulant use, and the risk for unintentional injuries leading to an admission was lower during episodes of stimulant, non-stimulant and stimulant and non-stimulant use.
Vasiliadis, Helen-Maria
95bd66f0-05b0-4763-9bc0-d80812f5953e
Lunghi, Carlotta
b45f4e11-5175-47d6-92c1-729d46130c74
Rahme, Elham
4b1fb3d2-e0c2-4fec-9fb6-f5d8eb5faad0
Rochette, Louis
30baa250-22bc-4f0d-971a-2296feacc9be
Gignac, Martin
2626c602-8c59-47c4-85ef-f696a78f41d6
Massamba, Victoria
f71ce7cd-72b7-4f04-b5fa-f8ab59da6dbb
Binta Diallo, Fatoumata
e72e73b3-451d-4276-a963-5d762a5959f6
Fansi, Alvine
1387b4a9-9802-41ba-8418-700e5452ece0
Cortese, Samuele
53d4bf2c-4e0e-4c77-9385-218350560fdb
Lesage, Alain
5fa71409-4cc4-4de8-a134-4bac790c4ee4
28 February 2024
Vasiliadis, Helen-Maria
95bd66f0-05b0-4763-9bc0-d80812f5953e
Lunghi, Carlotta
b45f4e11-5175-47d6-92c1-729d46130c74
Rahme, Elham
4b1fb3d2-e0c2-4fec-9fb6-f5d8eb5faad0
Rochette, Louis
30baa250-22bc-4f0d-971a-2296feacc9be
Gignac, Martin
2626c602-8c59-47c4-85ef-f696a78f41d6
Massamba, Victoria
f71ce7cd-72b7-4f04-b5fa-f8ab59da6dbb
Binta Diallo, Fatoumata
e72e73b3-451d-4276-a963-5d762a5959f6
Fansi, Alvine
1387b4a9-9802-41ba-8418-700e5452ece0
Cortese, Samuele
53d4bf2c-4e0e-4c77-9385-218350560fdb
Lesage, Alain
5fa71409-4cc4-4de8-a134-4bac790c4ee4
Vasiliadis, Helen-Maria, Lunghi, Carlotta, Rahme, Elham, Rochette, Louis, Gignac, Martin, Massamba, Victoria, Binta Diallo, Fatoumata, Fansi, Alvine, Cortese, Samuele and Lesage, Alain
(2024)
ADHD medications use and risk of mortality and unintentional injuries: a population-based cohort study.
Translational Psychiatry, 14, [128].
(doi:10.1038/s41398-024-02825-y).
Abstract
We assessed the association between the use of medications for attention-deficit/hyperactivity disorder (ADHD) and the risk of all-cause mortality and unintentional injuries leading to emergency department (ED) or hospital admission in individuals aged ≤24 years with ADHD. We conducted a population-based retrospective cohort study between 2000 and 2021 using Quebec health administrative data. Individuals were followed from the first ADHD diagnosis or ADHD medication claim until turning 25, death, or study end. Exposure was defined as mutually exclusive episodes of ADHD medication use and/or coverage under the public provincial drug plan (PDP): 1) covered and not treated with ADHD medication; 2) covered and treated with ADHD medication; and 3) not covered under the PDP. The risk of all-cause mortality and unintentional injuries associated with exposure episodes was estimated using multivariable survival analyses. The cohort included n=217 192 individuals aged 1 to 24 years with a male to female ratio of close to 2:1. Compared to non-medication use, episodes of ADHD medication use, overall, were associated with reduced all-cause mortality (adjusted hazard ratio, aHR 0.61, 95% CI 0.48 to 0.76) and unintentional injury leading to ED (0.75, 0.74 to 0.77) or hospitalisation (0.71, 0.68 to 0.75). Episodes of stimulants were associated with a lower risk of all-cause mortality and reduced risk of unintentional injuries, while episodes with non-stimulants and with both stimulants and non-stimulants concomitantly were associated with reduced risk of unintentional injuries, but not of all-cause mortality. Although residual confounding cannot be excluded, stimulants may have a protective effect in terms of risk of all-cause mortality and both stimulants and non-stimulants for ADHD may reduce the risk of unintentional injuries. Clinical implications of findings are that the risk of all-cause mortality was lower during episodes of stimulant use for ADHD but not with non-psychostimulant use, and the risk for unintentional injuries leading to an admission was lower during episodes of stimulant, non-stimulant and stimulant and non-stimulant use.
Text
ADHD medications use and risk of mortality
- Accepted Manuscript
Text
s41398-024-02825-y
- Version of Record
More information
Accepted/In Press date: 13 February 2024
Published date: 28 February 2024
Identifiers
Local EPrints ID: 492409
URI: http://eprints.soton.ac.uk/id/eprint/492409
PURE UUID: b39e8aaa-2b42-4069-abb0-acd4bc30b9a6
Catalogue record
Date deposited: 25 Jul 2024 17:24
Last modified: 26 Jul 2024 01:48
Export record
Altmetrics
Contributors
Author:
Helen-Maria Vasiliadis
Author:
Carlotta Lunghi
Author:
Elham Rahme
Author:
Louis Rochette
Author:
Martin Gignac
Author:
Victoria Massamba
Author:
Fatoumata Binta Diallo
Author:
Alvine Fansi
Author:
Alain Lesage
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics